Home/Filings/4/0001121781-12-000255
4//SEC Filing

FAUPEL MARK L 4

Accession 0001121781-12-000255

CIK 0000924515other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 5:32 PM ET

Size

6.5 KB

Accession

0001121781-12-000255

Insider Transaction Report

Form 4
Period: 2012-06-26
FAUPEL MARK L
DirectorCEO and President
Transactions
  • Award

    Common Stock

    2012-06-26$0.65/sh+153,846$100,000253,846 total
  • Award

    Common Stock

    2012-06-26$0.79/sh+13,630$10,768267,476 total
Footnotes (2)
  • [F1]Represents conversion of debt of $100,000 into 153,846 shares of common stock at $0.65 per share.
  • [F2]Represents conversion of debt of $8,614.12 into 13,630 shares of common stock at $0.632 per share.

Issuer

GUIDED THERAPEUTICS INC

CIK 0000924515

Entity typeother

Related Parties

1
  • filerCIK 0001223383

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:32 PM ET
Size
6.5 KB